These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30307897)

  • 1. Severe hyperchylomicronemia in two infants with novel APOC2 gene mutation.
    Kose E; Armagan C; Teke Kısa P; Onay H; Arslan N
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1289-1293. PubMed ID: 30307897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency.
    Okubo M; Toromanovic A; Ebara T; Murase T
    Clin Chim Acta; 2015 Jan; 438():148-53. PubMed ID: 25172036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene.
    Takase S; Osuga J; Fujita H; Hara K; Sekiya M; Igarashi M; Takanashi M; Takeuchi Y; Izumida Y; Ohta K; Kumagai M; Nishi M; Kubota M; Masuda Y; Taira Y; Okazaki S; Iizuka Y; Yahagi N; Ohashi K; Yoshida H; Yanai H; Tada N; Gotoda T; Ishibashi S; Kadowaki T; Okazaki H
    J Atheroscler Thromb; 2013; 20(5):481-93. PubMed ID: 23470567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome.
    Lam CW; Yuen YP; Cheng WF; Chan YW; Tong SF
    Clin Chim Acta; 2006 Feb; 364(1-2):256-9. PubMed ID: 16153625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.
    Chokshi N; Blumenschein SD; Ahmad Z; Garg A
    J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.
    Charrière S; Peretti N; Bernard S; Di Filippo M; Sassolas A; Merlin M; Delay M; Debard C; Lefai E; Lachaux A; Moulin P; Marçais C
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1675-9. PubMed ID: 21816778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary hyperchylomicronemia].
    Yamashita S
    Nihon Rinsho; 2013 Sep; 71(9):1578-83. PubMed ID: 24205717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of acute pancreatitis due to apolipoprotein C-II deficiency in a 37-day-old infant.
    Yıldız Y; Uysal Yazıcı M; Çınar HG; Özbay Hoşnut F; Kurt Çolak F; Kılıç M
    Pancreatology; 2020 Jun; 20(4):644-646. PubMed ID: 32205061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients.
    Liu C; Gaudet D; Miller YI
    PLoS One; 2017; 12(1):e0169939. PubMed ID: 28107429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial hyperchylomicronemia with a new mutation of the lipoprotein lipase gene].
    Causeret AS; Souillet AL; Marcais C; Prunetta V; Lachaux A; Faure M; Claudy A
    Ann Dermatol Venereol; 2001 Dec; 128(12):1343-5. PubMed ID: 11908140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional characterization of familial chylomicronemia syndrome.
    Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.
    Sakurai T; Sakurai A; Vaisman BL; Amar MJ; Liu C; Gordon SM; Drake SK; Pryor M; Sampson ML; Yang L; Freeman LA; Remaley AT
    J Pharmacol Exp Ther; 2016 Feb; 356(2):341-53. PubMed ID: 26574515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
    Ariza MJ; Rioja J; Ibarretxe D; Camacho A; Díaz-Díaz JL; Mangas A; Carbayo-Herencia JA; Ruiz-Ocaña P; Lamíquiz-Moneo I; Mosquera D; Sáenz P; Masana L; Muñiz-Grijalvo O; Pérez-Calahorra S; Valdivielso P;
    J Clin Lipidol; 2018; 12(6):1482-1492.e3. PubMed ID: 30150141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
    Martín-Campos JM; Julve J; Roig R; Martínez S; Errico TL; Martínez-Couselo S; Escolà-Gil JC; Méndez-González J; Blanco-Vaca F
    Clin Chim Acta; 2014 Feb; 429():61-8. PubMed ID: 24291057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis.
    Ueda M; Dunbar RL; Wolska A; Sikora TU; Escobar MDR; Seliktar N; deGoma E; DerOhannessian S; Morrell L; McIntyre AD; Burke F; Sviridov D; Amar M; Shamburek RD; Freeman L; Hegele RA; Remaley AT; Rader DJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1454-1457. PubMed ID: 28201738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment.
    Stefanutti C; Gozzer M; Pisciotta L; D'Eufemia P; Bosco G; Morozzi C; Papadia F; Shafii M; Di Giacomo S; Bertolini S
    Atheroscler Suppl; 2013 Jan; 14(1):73-6. PubMed ID: 23357145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome.
    Paquette M; Hegele RA; Paré G; Baass A
    J Clin Lipidol; 2018; 12(2):506-510. PubMed ID: 29452893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia.
    Liu C; Gates KP; Fang L; Amar MJ; Schneider DA; Geng H; Huang W; Kim J; Pattison J; Zhang J; Witztum JL; Remaley AT; Dong PD; Miller YI
    Dis Model Mech; 2015 Aug; 8(8):989-98. PubMed ID: 26044956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary hyperchylomicronemia and gene defects].
    Iwasaki M; Tada N
    Nihon Rinsho; 1999 Dec; 57(12):2759-64. PubMed ID: 10638209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1.
    Ahmad Z; Wilson DP
    J Clin Lipidol; 2014; 8(6):635-639. PubMed ID: 25499947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.